Examining fraud in U.S. Medicare and Medicaid: shifting focus from patient eligibility to provider and insurer fraudulent practices amid congressional budget cuts and regulatory challenges.

CMS intensifies efforts to detect and prevent healthcare fraud, waste, and abuse in Medicare and Medicaid programs, encouraging stakeholder reporting to safeguard taxpayer funds.

Rodney L. Yentzer sentenced to 42 months for defrauding Medicare and Medicaid through unnecessary urine drug tests, resulting in multi-million dollar restitution. Case underscores insurance fraud risks in healthcare diagnostic billing.

Vault Medical Services agreed to pay $8 million to resolve False Claims Act allegations for improper COVID-19 billing under the federal Uninsured Program, highlighting compliance risks in federally funded healthcare programs.

U.S. cancer death rates declined steadily from 2001 to 2022, including during the pandemic, driven by advances in detection and treatment. Regulatory fraud enforcement and new FDA approvals impact healthcare and insurance sectors.

A Florida executive pleaded guilty in a $134M fraud scheme involving falsified ACA insurance subsidy applications, highlighting ongoing regulatory enforcement in healthcare.